Epstein Secrets

54.530 65.449 70.672 75,619 80,157 Net laconic ($28.730) $2.226 $28,487 $51.036 $79.385 $95.281 $102,884 $110,086 $116,692 AL/regale Business Model (Common tilm) 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Revenue 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 10

et, 3 ni floor San Francisco, CA 94103 Dear Mr. Tamaru: We have completed our analysis of the fair market value of the common equity of AliphCom ("Aliph" or the "Company") on a per share basis (the "Subject Interest") as of June 20, 2011 (the "Valuation Date"). We understand that our valuation of th

54.530 65.449 70.672 75,619 80,157 Net laconic ($28.730) $2.226 $28,487 $51.036 $79.385 $95.281 $102,884 $110,086 $116,692 AL/regale Business Model (Common tilm) 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Revenue 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 10

et, 3 ni floor San Francisco, CA 94103 Dear Mr. Tamaru: We have completed our analysis of the fair market value of the common equity of AliphCom ("Aliph" or the "Company") on a per share basis (the "Subject Interest") as of June 20, 2011 (the "Valuation Date"). We understand that our valuation of th

54.530 65.449 70.672 75,619 80,157 Net laconic ($28.730) $2.226 $28,487 $51.036 $79.385 $95.281 $102,884 $110,086 $116,692 AL/regale Business Model (Common tilm) 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Revenue 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 10

et, 3 ni floor San Francisco, CA 94103 Dear Mr. Tamaru: We have completed our analysis of the fair market value of the common equity of AliphCom ("Aliph" or the "Company") on a per share basis (the "Subject Interest") as of June 20, 2011 (the "Valuation Date"). We understand that our valuation of th